Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 8,044 $ 11,645
Restricted cash 312 251
Accounts receivable, less allowance of $850 and $802 in 2018 and 2017, respectively 11,112 10,124
Inventory 12,248 12,298
Prepaid expenses and other current assets 1,591 1,732
Total current assets 33,307 36,050
Property, plant, and equipment, net 1,975 3,674
Goodwill 2,926 2,926
Other assets 308 334
Total assets 38,516 42,984
Current liabilities:    
Accounts payable 5,953 5,109
Accrued liabilities 7,538 5,636
Deferred revenue 2,476 2,625
Total current liabilities 15,967 13,370
Deferred income taxes, net 77 104
Warranty accrual 447 70
Other liabilities 100 180
Term loan 10,836  
Total liabilities 27,427 13,724
Commitments and contingencies —Note 6
Stockholders' equity:    
Preferred stock, par value $0.001 per share; 1,000 shares authorized, 0 shares issued and outstanding as of December 31, 2018 and 2017, respectively
Common stock, par value $0.001 per share; 40,000 and 40,000 shares authorized, 21,072 and 20,468 shares issued and outstanding as of December 31, 2018 and 2017, respectively 21 20
Additional paid-in capital 228,430 224,992
Accumulated other comprehensive loss (670) (576)
Accumulated deficit (216,692) (195,176)
Total stockholders' equity 11,089 29,260
Total liabilities and stockholders' equity $ 38,516 $ 42,984